Following the October 16, 2026 options expiration, all four open option positions across our portfolio expired completely out of the money and worthless. In accordance with our strategy, 100% of the initial premium collected upon entry has been retained as realized cash profit with zero closing cost.
Closed Positions Summary
- IBM Oct 2026 300.000 Call (Hedge): Expired worthless. Premium collected: +$5,297.00
- META Oct 2026 550.000 Put: Expired worthless. Premium collected: +$4,825.00
- EWY Oct 2026 150.000 Put: Expired worthless. Premium collected: +$1,771.00
- AstraZeneca Oct 2026 165.000 Put: Expired worthless. Premium collected: +$2,620.00
- Total Realized Gain: +$14,513.00
Expiration Breakdown
| Symbol | Description | Contracts | Strike | Exit Price | Realized P/L |
|---|---|---|---|---|---|
| IBM261016C | IBM Oct 2026 Call (Hedge) | 1 (100) | $300.00 | $0.00 | +$5,297.00 |
| META261016 | META Oct 2026 Put | 1 (100) | $550.00 | $0.00 | +$4,825.00 |
| EWY261016P | EWY Oct 2026 Put | 1 (100) | $150.00 | $0.00 | +$1,771.00 |
| AZN261016P | AstraZeneca Oct 2026 Put | 2 (200) | $165.00 | $0.00 | +$2,620.00 |
Portfolio Accounting & Next Steps
All four contracts have been fully settled and closed out at zero value in our portfolio management system. The positions have moved to the Closed Positions register, locking in the full $14,513.00 cash proceeds into our cumulative realized performance.
Portfolio Status
With the October expiry cycle cleanly completed, our risk exposure is fully reset as we evaluate fresh opportunities across high-conviction ideas.